Traylor Margie L. 4
4 · Augmedix, Inc. · Filed May 17, 2023
Insider Transaction Report
Form 4
Augmedix, Inc.AUGX
Traylor Margie L.
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2023-05-15−10,182→ 0 totalExercise: $2.20Exp: 2032-03-03→ Common Stock (10,182 underlying) - Exercise/Conversion
Common Stock
2023-05-15$2.20/sh+10,182$22,400→ 20,801 total
Footnotes (2)
- [F1]This transaction reflects a cash exercise of a stock option, awarded under the Augmedix, Inc. 2020 Equity Incentive Plan, without a subsequent sale of the underlying shares of common stock.
- [F2]Fully vested.